EPISODE · Dec 23, 2025 · 8 MIN
Donanemab : on fait le point
from Focus
Focus sur le Donanemab (Kisunla), récemment approuvé par l'Agence européenne des médicaments. 📅 Après un refus en mars 2025, ce traitement novateur a finalement reçu le feu vert européen le 25 septembre dernier. Mais que change-t-il concrètement pour les patients et surtout : qu'en est-il des prochaines étapes en France ?
Embed this episode
Ready to play
Donanemab : on fait le point
0:00
8:20
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Focus?
This episode is 8 minutes long.
When was this Focus episode published?
This episode was published on December 23, 2025.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this Focus episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!